Outer-Membrane Vesicles from Gram-Negative Bacteria: Biogenesis and Functions
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease
toxins Review Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease Rosalia Marcano 1, M. Ángeles Rojo 2 , Damián Cordoba-Diaz 3 and Manuel Garrosa 1,* 1 Department of Cell Biology, Histology and Pharmacology, Faculty of Medicine and INCYL, University of Valladolid, 47005 Valladolid, Spain; [email protected] 2 Area of Experimental Sciences, Miguel de Cervantes European University, 47012 Valladolid, Spain; [email protected] 3 Area of Pharmaceutics and Food Technology, Faculty of Pharmacy, and IUFI, Complutense University of Madrid, 28040 Madrid, Spain; [email protected] * Correspondence: [email protected] Abstract: It is widely recognized that periodontal disease is an inflammatory entity of infectious origin, in which the immune activation of the host leads to the destruction of the supporting tissues of the tooth. Periodontal pathogenic bacteria like Porphyromonas gingivalis, that belongs to the complex net of oral microflora, exhibits a toxicogenic potential by releasing endotoxins, which are the lipopolysaccharide component (LPS) available in the outer cell wall of Gram-negative bacteria. Endotoxins are released into the tissues causing damage after the cell is lysed. There are three well-defined regions in the LPS: one of them, the lipid A, has a lipidic nature, and the other two, the Core and the O-antigen, have a glycosidic nature, all of them with independent and synergistic functions. Lipid A is the “bioactive center” of LPS, responsible for its toxicity, and shows great variability along bacteria. In general, endotoxins have specific receptors at the cells, causing a wide immunoinflammatory response by inducing the release of pro-inflammatory cytokines and the production of matrix metalloproteinases. -
Role of Vimf in Gingipain Maturation in Porphyromonas Gingivalis Arun S
Loma Linda University TheScholarsRepository@LLU: Digital Archive of Research, Scholarship & Creative Works Loma Linda University Electronic Theses, Dissertations & Projects 9-1-2013 Role of VimF in Gingipain Maturation in Porphyromonas gingivalis Arun S. Muthiah Loma Linda University Follow this and additional works at: http://scholarsrepository.llu.edu/etd Part of the Medical Genetics Commons, and the Medical Microbiology Commons Recommended Citation Muthiah, Arun S., "Role of VimF in Gingipain Maturation in Porphyromonas gingivalis" (2013). Loma Linda University Electronic Theses, Dissertations & Projects. 139. http://scholarsrepository.llu.edu/etd/139 This Dissertation is brought to you for free and open access by TheScholarsRepository@LLU: Digital Archive of Research, Scholarship & Creative Works. It has been accepted for inclusion in Loma Linda University Electronic Theses, Dissertations & Projects by an authorized administrator of TheScholarsRepository@LLU: Digital Archive of Research, Scholarship & Creative Works. For more information, please contact [email protected]. LOMA LINDA UNIVERSITY School of Medicine in conjunction with the Faculty of Graduate Studies ____________________ Role of VimF in Gingipain Maturation in Porphyromonas gingivalis by Arun S Muthiah ____________________ A Dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Microbiology and Molecular Genetics ____________________ September 2013 © 2013 Arun S Muthiah All Rights Reserved Each person whose -
Serine Proteases with Altered Sensitivity to Activity-Modulating
(19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants. -
(12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier Et Al
US 200601 10747A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier et al. (43) Pub. Date: May 25, 2006 (54) PROCESS FOR IMPROVED PROTEIN (60) Provisional application No. 60/591489, filed on Jul. EXPRESSION BY STRAIN ENGINEERING 26, 2004. (75) Inventors: Thomas M. Ramseier, Poway, CA Publication Classification (US); Hongfan Jin, San Diego, CA (51) Int. Cl. (US); Charles H. Squires, Poway, CA CI2O I/68 (2006.01) (US) GOIN 33/53 (2006.01) CI2N 15/74 (2006.01) Correspondence Address: (52) U.S. Cl. ................................ 435/6: 435/7.1; 435/471 KING & SPALDING LLP 118O PEACHTREE STREET (57) ABSTRACT ATLANTA, GA 30309 (US) This invention is a process for improving the production levels of recombinant proteins or peptides or improving the (73) Assignee: Dow Global Technologies Inc., Midland, level of active recombinant proteins or peptides expressed in MI (US) host cells. The invention is a process of comparing two genetic profiles of a cell that expresses a recombinant (21) Appl. No.: 11/189,375 protein and modifying the cell to change the expression of a gene product that is upregulated in response to the recom (22) Filed: Jul. 26, 2005 binant protein expression. The process can improve protein production or can improve protein quality, for example, by Related U.S. Application Data increasing solubility of a recombinant protein. Patent Application Publication May 25, 2006 Sheet 1 of 15 US 2006/0110747 A1 Figure 1 09 010909070£020\,0 10°0 Patent Application Publication May 25, 2006 Sheet 2 of 15 US 2006/0110747 A1 Figure 2 Ester sers Custer || || || || || HH-I-H 1 H4 s a cisiers TT closers | | | | | | Ya S T RXFO 1961. -
Liquid Crystalline Bacterial Outer Membranes Are Critical for Antibiotic Susceptibility
Liquid crystalline bacterial outer membranes are critical for antibiotic susceptibility Nicolò Paracinia, Luke A. Cliftonb, Maximilian W. A. Skodab, and Jeremy H. Lakeya,1 aInstitute for Cell and Molecular Biosciences, The Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom; and bISIS Pulsed Neutron and Muon Source, Science and Technology Facilities Council (STFC), Rutherford Appleton Laboratory, Didcot, Oxfordshire OX11 OQX, United Kingdom Edited by Hiroshi Nikaido, University of California, Berkeley, CA, and approved June 21, 2018 (received for review March 6, 2018) The outer membrane (OM) of Gram-negative bacteria is a robust, The OM is difficult to precisely address by biophysical methods impermeable, asymmetric bilayer of outer lipopolysaccharides (LPSs) in vivo, largely because of the close proximity of the inner mem- and inner phospholipids containing selective pore proteins which brane. This has led to considerable debate concerning its structure confer on it the properties of a molecular sieve. This structure severely and dynamics (9). Although its asymmetric lipid distribution was limits the variety of antibiotic molecules effective against Gram- initially controversial, it is now widely accepted that LPS is the negative pathogens and, as antibiotic resistance has increased, so has major lipid component of the outer leaflet while phospholipids are the need to solve the OM permeability problem. Polymyxin B (PmB) confined to the periplasmic side of the membrane (1). However, represents those rare antibiotics which act directly on the OM and while plasma membranes are generally accepted to be fluid sys- which offer a distinct starting point for new antibiotic development. tems, the physical state of OM lipids remains unclear. -
Versatile Effects of Bacterium-Released Membrane Vesicles on Mammalian Cells and Infectious/ Inflammatory Diseases
Acta Pharmacologica Sinica (2018) 39: 514–533 © 2018 CPS and SIMM All rights reserved 1671-4083/18 www.nature.com/aps Review Article Versatile effects of bacterium-released membrane vesicles on mammalian cells and infectious/ inflammatory diseases You-jiang YU1, Xiao-hong WANG2, Guo-Chang FAN2, * 1Medical College of Yangzhou Polytechnic College, Yangzhou 225009, China; 2Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA Abstract Gram-negative bacterium-released outer-membrane vesicles (OMVs) and Gram-positive bacterium-released membrane vesicles (MVs) share significant similarities with mammalian cell-derived MVs eg( , microvesicles and exosomes) in terms of structure and their biological activities. Recent studies have revealed that bacterial OMVs/MVs could (1) interact with immune cells to regulate inflammatory responses, (2) transport virulence factors (eg, enzymes, DNA and small RNAs) to host cells and result in cell injury, (3) enhance barrier function by stimulating the expression of tight junction proteins in intestinal epithelial cells, (4) upregulate the expression of endothelial cell adhesion molecules, and (5) serve as natural nanocarriers for immunogenic antigens, enzyme support and drug delivery. In addition, OMVs/MVs can enter the systemic circulation and induce a variety of immunological and metabolic responses. This review highlights the recent advances in the understanding of OMV/MV biogenesis and their compositional remodeling. In addition, interactions between OMVs/MVs and various types of mammalian cells (ie, immune cells, epithelial cells, and endothelial cells) and their pathological/preventive effects on infectious/inflammatory diseases are summarized. Finally, methods for engineering OMVs/MVs and their therapeutic potential are discussed. -
Analysis of Genes Involved in Anaerobic Growth In
University of Wisconsin Milwaukee UWM Digital Commons Theses and Dissertations May 2013 Analysis of Genes Involved in Anaerobic Growth in Porphyromonas Gingivalis and Shewanella Oneidensis MR-1 Dilini Sanjeevi Kumarasinghe University of Wisconsin-Milwaukee Follow this and additional works at: https://dc.uwm.edu/etd Part of the Biology Commons, and the Microbiology Commons Recommended Citation Kumarasinghe, Dilini Sanjeevi, "Analysis of Genes Involved in Anaerobic Growth in Porphyromonas Gingivalis and Shewanella Oneidensis MR-1" (2013). Theses and Dissertations. 387. https://dc.uwm.edu/etd/387 This Thesis is brought to you for free and open access by UWM Digital Commons. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of UWM Digital Commons. For more information, please contact [email protected]. ANALYSIS OF GENES INVOLVED IN ANAEROBIC GROWTH IN Porphyromonas gingivalis AND Shewanella oneidensis MR-1 by Dilini Kumarasinghe A thesis Submitted in Partial Fulfillment of the Requirements for the Degree of Master of Science in Biological Sciences at The University of Wisconsin-Milwaukee May 2013 ABSTRACT Analysis of genes involved in anaerobic growth in Porphyromonas gingivalis and Shewanella oneidensis MR-1 by Dilini Kumarasinghe The University of Wisconsin-Milwaukee, 2013 Under the Supervision of Professor Daâd Saffarini Porphyromonas gingivalis is an oral Gram-negative anaerobic bacterium implicated in periodontal disease, a polymicrobial inflammatory disease that is correlated with cardiovascular disease, diabetes and preterm birth. Therefore understanding the physiology and metabolism of P.gingivalis through genetic manipulation is important in identifying mechanisms to eliminate this pathogen. Although numerous genetic tools have been developed for the manipulation of other bacterial species, they either do not function in P.gingivalis or they have limitations. -
The Role of Outer Membrane Proteins of Porphyromonas Gingivalis in Host-Pathogen Interactions Kathryn Lucy Naylor
The Role of Outer Membrane Proteins of Porphyromonas gingivalis in Host-Pathogen Interactions By: Kathryn Lucy Naylor A thesis submitted in partial fulfilment of the requirements for the degree of Doctor of Philosophy The University of Sheffield Faculty of Medicine, Dentistry and Health School of Clinical Dentistry 23 / 08 / 2016 Summary The keystone periodontal pathogen, P. gingivalis, is a Gram-negative oral anaerobe that is strongly implicated as the prime etiological agent in the initiation and progression of periodontal disease. P. gingivalis contains a plethora of virulence factors, including fimbriae, proteases, lipopolysaccharides and outer membrane proteins that contribute to the pathogenesis of the disease. The bacterium also displays the ability to interact with host cells through the adherence and invasion both in vitro and in vivo. In this thesis new light has been shed on the role of the heterotrimeric outer membrane protein A (OmpA). Through the creation of ompA mutants and recombinant complementation plasmids, alongside the use of standard antibiotic protection assays in an oral epithelial cell line, this research has demonstrated the importance of OmpA, specifically the OmpA2 subunit, in the invasion of the host and in the ability of the bacteria to form biofilms. Structural analysis of the protein identified extracellular loops, which when synthetic versions were applied to host cells, demonstrated successful interruption of wild-type P. gingivalis adherence and invasion of the host, indicating a direct interaction of OmpA2 with oral epithelial cells. In particular, this research demonstrates that OmpA2-loop 4 plays an important role in the interaction with the host through significantly increased binding to host cells when applied to fluorescent latex beads. -
Bacteriophage-Derived Endolysins Applied As Potent Biocontrol Agents to Enhance Food Safety
microorganisms Review Bacteriophage-Derived Endolysins Applied as Potent Biocontrol Agents to Enhance Food Safety Yoonjee Chang Department of Food and Nutrition, Kookmin University, Seoul 02707, Korea; [email protected]; Tel.: +82-2-910-4775 Received: 27 April 2020; Accepted: 12 May 2020; Published: 13 May 2020 Abstract: Endolysins, bacteriophage-encoded enzymes, have emerged as antibacterial agents that can be actively applied in food processing systems as food preservatives to control pathogens and ultimately enhance food safety. Endolysins break down bacterial peptidoglycan structures at the terminal step of the phage reproduction cycle to enable phage progeny release. In particular, endolysin treatment is a novel strategy for controlling antibiotic-resistant bacteria, which are a severe and increasingly frequent problem in the food industry. In addition, endolysins can eliminate biofilms on the surfaces of utensils. Furthermore, the cell wall-binding domain of endolysins can be used as a tool for rapidly detecting pathogens. Research to extend the use of endolysins toward Gram-negative bacteria is now being extensively conducted. This review summarizes the trends in endolysin research to date and discusses the future applications of these enzymes as novel food preservation tools in the field of food safety. Keywords: endolysin; antimicrobial; biocontrol; disinfection; food safety 1. Introduction Contamination of food by foodborne pathogens is a serious issue in the food industry; for example, contamination by Staphylococcus aureus, Salmonella spp., Escherichia coli, Listeria monocytogenes, and Clostridium spp. during food processing can threaten human health and lead to economic losses [1]. Therefore, it is recognized that novel strategies to control pathogenic bacteria in foods are urgently required. -
Epidemiology and Pathogenesis of Moraxella Catarrhalis Colonization
Chirality: The Key to Specific Bacterial Protease-Based Diagnosis? Wendy E. Kaman ISBN 978-94-6169-451-5 © W.E. Kaman, Rotterdam, 2014 All rights reserved. No part of this thesis may be reproduced or transmitted in any form or by means without prior permission of the author, or where appropriate, the publisher of the articles. The printing of this thesis was financially supported by the Nederlandse Vereniging voor Medische Microbiologie. Layout and printing: Optima Grafische Communicatie Cover design: Suede Design (www.suededesign.nl) Chirality: The Key to Specific Bacterial Protease-Based Diagnosis? Chiraliteit: de sleutel tot bacterie-specifieke protease-gebaseerde diagnostiek? Proefschrift ter verkrijging van de graad van doctor aan de Erasmus Universiteit Rotterdam op gezag van de Rector Magnificus Prof. dr. H.A.P. Pols en volgens besluit van het College voor Promoties De openbare verdediging zal plaats vinden op 24 januari om 9:30 uur door Wendy Esmeralda Kaman geboren te `s-Gravenhage Promotiecommissie Promotor: Prof. dr. H.P. Endtz Overige leden: Prof. dr. E.C.I. Veerman Prof. dr. W. Crielaard Prof. dr. dr. A. van Belkum Co-promotoren: Dr. F.J. Bikker Dr. J.P. Hays It`s all about cleavage! Contents Amino acids 11 Introduction Chapter 1. General introduction, aim and outline of the thesis. 15 Diagnosis Chapter 2. Evaluation of a D-amino-acid-containing fluorescence resonance 39 energy transfer (FRET-) peptide library for profiling prokaryotic proteases. Chapter 3. Highly specific protease-based approach for detection ofPorphy- 59 romonas gingivalis in diagnosis of periodontitis. Chapter 4. Comparing culture, real-time PCR and FRET-technology for de- 81 tection of Porphyromonas gingivalis in patients with or without peri-implant infections. -
Inhibition of Gingipains by Their Profragments As the Mechanism Protecting Porphyromonas Gingivalis Against Premature Activation of Secreted Proteases
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Digital.CSIC Inhibition of gingipains by their profragments as the mechanism protecting Porphyromonas gingivalis against premature activation of secreted proteases Florian Veillard1,#, Maryta Sztukowska1,#, Danuta Mizgalska2, Miros!aw Ksiazek2, John Houston1, Barbara Potempa1, Jan J. Enghild3, Ida B. Thogersen3, F. Xavier Gomis-Rüth4, Ky-Anh Nguyen5,6, Jan Potempa1,2,* 1Oral Health and Systemic Diseases Research Group, University of Louisville School of Dentistry, Louisville, KY 40202, USA; e-mails: [email protected]; [email protected]; [email protected]; [email protected]; [email protected] 2Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland. e-mails: [email protected]; [email protected]; [email protected] 3Center for Insoluble Protein Structures (inSPIN) and Interdisciplinary Nanoscience Center (iNANO) at the Department of Molecular Biology and Genetics, Aarhus University, Aarhus DK- 8000, Denmark; e-mails: [email protected]; [email protected] 4Proteolysis Lab, Molecular Biology Institute of Barcelona, Spanish Research Council CSIC, Barcelona Science Park, c/Baldiri Reixac 15-21, 08028 Barcelona, Catalonia (Spain); e-mail: [email protected] 5Institute of Dental Research, Westmead Centre for Oral Health and Westmead Millenium Institute, Sydney NSW 2145, Australia; e-mail: [email protected] 6Faculty of Dentistry, University of Sydney, Sydney NSW 2006, Australia. #These authors contributed equally to this study and share first authorship. *Corresponding author phone number: (+1) 502-852-1319 Abbreviations: PD, N-terminal prodomain; CD, catalytic domain; CTD, C-terminal domain ABSTRACT Background: Arginine-specific (RgpB and RgpA) and lysine-specific (Kgp) gingipains are secretory cysteine proteinases of Porphyromonas gingivalis that act as important virulence factors for the organism. -
Inhibition of Gingipains by Their Profragments As the Mechanism Protecting Porphyromonas Gingivalis Against Premature Activation of Secreted Proteases
Inhibition of gingipains by their profragments as the mechanism protecting Porphyromonas gingivalis against premature activation of secreted proteases Florian Veillard1,#, Maryta Sztukowska1,#, Danuta Mizgalska2, Miros!aw Ksiazek2, John Houston1, Barbara Potempa1, Jan J. Enghild3, Ida B. Thogersen3, F. Xavier Gomis-Rüth4, Ky-Anh Nguyen5,6, Jan Potempa1,2,* 1Oral Health and Systemic Diseases Research Group, University of Louisville School of Dentistry, Louisville, KY 40202, USA; e-mails: [email protected]; [email protected]; [email protected]; [email protected]; [email protected] 2Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland. e-mails: [email protected]; [email protected]; [email protected] 3Center for Insoluble Protein Structures (inSPIN) and Interdisciplinary Nanoscience Center (iNANO) at the Department of Molecular Biology and Genetics, Aarhus University, Aarhus DK- 8000, Denmark; e-mails: [email protected]; [email protected] 4Proteolysis Lab, Molecular Biology Institute of Barcelona, Spanish Research Council CSIC, Barcelona Science Park, c/Baldiri Reixac 15-21, 08028 Barcelona, Catalonia (Spain); e-mail: [email protected] 5Institute of Dental Research, Westmead Centre for Oral Health and Westmead Millenium Institute, Sydney NSW 2145, Australia; e-mail: [email protected] 6Faculty of Dentistry, University of Sydney, Sydney NSW 2006, Australia. #These authors contributed equally to this study and share first authorship. *Corresponding author phone number: (+1) 502-852-1319 Abbreviations: PD, N-terminal prodomain; CD, catalytic domain; CTD, C-terminal domain ABSTRACT Background: Arginine-specific (RgpB and RgpA) and lysine-specific (Kgp) gingipains are secretory cysteine proteinases of Porphyromonas gingivalis that act as important virulence factors for the organism.